Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia

Medicine and Dentistry

• Patient 80%
• B-Cell Chronic Lymphocytic Leukemia 60%
• Multiple Myeloma 50%
• Menogaril 40%
• Lymphocytic Lymphoma 30%
• Therapeutic Procedure 30%
• Inpatient 20%
• Diseases 10%
• Toxicity 10%
• Chemotherapy 10%
• Phase II Trials 10%
• Progressive Disease 10%
• Anthracycline 10%
• Intravenous Drug Administration 10%
• Chemotherapy Regimens 10%
• Sepsis 10%
• Cardiotoxicity 10%
• Symptom 10%

INIS

• patients 100%
• leukemia 60%
• lymphomas 30%
• diseases 20%
• chemotherapy 20%
• toxicity 10%
• infusion 10%
• symptoms 10%